Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Innovent Biologics Receives Approval for Ipilimumab Injection in Colon Cancer Treatment
Monday, February 24, 2025Innovent Biologics has announced that the New Drug Application NDA for its ipilimumab injection an antiCTLA monoclonal antibody RD Code IBI has been accepted by the Centre for Drug Evaluation CDE of Chinas National Medical Products Administration NMP...
Bonus Biogroup Receives Approval for MesenCure in Acute Respiratory Distress Syndrome Treatment
Friday, February 21, 2025Bonus Biogroup has received clearance from the United States Food and Drug Administration FDA to proceed with a Phase III clinical study ARDS can develop due to pneumonia sepsis or trauma often resulting in respiratory failure and a high mortality ra...
Harbour BioMed Enters into Collaboration with Insilico Medicine for Antibody Discovery and Development
Friday, February 21, 2025Harbour BioMed has entered a strategic collaboration with Insilico Medicine The partnership aims to accelerate the development of innovative therapeutic antibodies by combining expertise in AI technology and antibody research
Specialised Therapeutics Secures Approval for YORVIPATH® in Chronic Hypoparathyroidism Treatment
Friday, February 21, 2025Specialised Therapeutics ST has announced the approval of YORVIPATH palopegteriparatide by the Therapeutic Goods Administration TGA for the treatment of chronic hypoparathyroidism in adults
AskBio Receives Approval on Regenerative Medicine for Investigational Parkinson’s Disease Treatment
Thursday, February 20, 2025AskBio has received Regenerative Medicine Advanced Therapy RMAT designation from the United States Food and Drug Administration FDA for AB an investigational gene therapy for Parkinsons disease PD
Boehringer Receives FDA Approval for Zongertinib in HER2-Mutant Advanced NSCLC Treatment
Thursday, February 20, 2025Boehringer Ingelheim has announced that the US Food and Drug Administration FDA has granted Priority Review to its new drug application for zongertinib BI Lung cancer remains a leading cause of cancerrelated deaths with cases expected to exceed thre...
Biogen Enters into Collaboration with Stoke Therapeutics to Develop Zorevunersen for Dravet Syndrome Treatment
Wednesday, February 19, 2025Biogen and Stoke Therapeutics have announced a collaboration to develop and commercialise zorevunersen a potential firstinclass diseasemodifying treatment for Dravet syndrome
Clarity Receives Approval for Cu-67 SAR-bisPSMA in Prostate Cancer
Wednesday, February 19, 2025Clarity Pharmaceuticals has announced that the United States Food and Drug Administration FDA has granted Fast Track Designation FTD for CuSARbisPSMAProstate cancer is the second most commonly diagnosed cancer in men worldwide and ranks as the fifth...
InnoCare Secures Approval of Orelabrutinib for the Treatment of CLL/SLL
Tuesday, February 18, 2025InnoCare Pharma has received approval from Chinas Centre for Drug Evaluation CDE of the National Medical Products Administration NMPA to proceed with a Phase III clinical trial
Innovent’s IBI363 Gains FDA Fast Track Status for Squamous Non-Small Cell Lung Cancer Therapy
Tuesday, February 18, 2025Innovent Biologics has received a second Fast Track Designation FTD from the US Food and Drug Administration FDA for its PDILbias bispecific antibody fusion protein IBI
